Method of treating gastrointestinal pathology of non-infectious aethiology in calves

FIELD: medicine.

SUBSTANCE: invention refers to veterinary science and aims at treating a gastrointestinal pathology of non-infectious aethiology in calves. Acupuncture points are exposed to a remote therapeutic massage electrode No.1 of DiaDENS-PC apparatus in the 'Therapy' regimen with alternating frequencies of 77 Hz and 10 Hz on the acupuncture points located along the median sagittal line between the spinous processes of the thoracic spine, for 5 minutes, followed by introducing the medicine 'Liarsin' in a dose of 0.5 ml in the area of a biologically active point located between the spinous processes of the last thoracic and first lumbar vertebrae.

EFFECT: method has the high therapeutic efficacy and eliminates local allergic reactions, causes no anxiety in an animal.

1 ex

 

The invention relates to veterinary medicine, in particular to electro and homeopathic methods, and can be used in the treatment of diseases having a testimony to the electro and homeopathy.

There is a method of prevention and treatment of diseases of the gastrointestinal tract of cattle by intramuscular injection of homeopathic drug "Larsen" in a dose of 3-5 ml per animal (the Use of drugs "HELMET" animal husbandry (Description of drugs, schemes and methods of application) / the Group of companies "HELMET". - [BMI]:[B. I.], 2010. - C.5.).

However, prophylactic and therapeutic effect in diseases of the gastrointestinal tract of cattle is very significant doses of the drug.

There is a method of treatment of diseases of the digestive system, cardiovascular, respiratory and urinary systems of cattle by the impact of acupuncture on acupuncture points (TA) 10-17 located on dorsomedial line between 1-m and 2-m 3-m 4-m 5-m 6-m 6-m 7-m 8-m 9-m 10-m 11-m; the 11th and 12th thoracic vertebrae and the last thoracic (13-m) and The 1st lumbar vertebrae (Gwisai Veterinary acupuncture (scientific-practical guide). - M.: RIO RSACU, 2000. - S, 266-277).

However, the impact on acupuncture points through acupuncture is syvaet great concern to animal and requires additional conditions of fixation. The method is not applied in the gastro-intestinal pathology calves non-infectious etiology.

There is a method of treatment of animals exposed to acupuncture points by reflexionyliberacion, including the effects of drug on acupuncture points, characterized in that the acupuncture points rubbing warmed to 30-35C. a solution consisting of: iodine crystal - 0.6 g, potassium iodide, 0.6 g, powdered paraffin - 13,0 g, dissolved it in chloroform is 75.0 ml and infused at room temperature for 48-72 hours in a vessel made of dark glass with a glass lid and affect the acupuncture point within 3-30 minutes (Patent No. 2412695 treatment of animals exposed to acupuncture points by reflexionyliberacion FGOU VPO Dallgow; rabuka VA, rabuka AV, Codelco A.A., Miller, T., Astakhova M.E. Ter-Minassian, Sumarokovskiy AV - No. 2010100745/15; Appl. 11.01.2010; publ. 27.02.2011, bull. No. 6).

However, the impact of the drug on acupuncture points by rubbing difficult to apply in the cold season due to the difficulty to maintain a constant used drug in the required temperature 30-35C. In this case, the drug has a side effect in the form of significant local allergic reactions, which is of great concern to the animal. The method is not applied in the gastro-intestinal pathology testdatabase etiology.

The task of the claimed invention is to reduce the amount of typing a medicinal product, the determination of the frequency of the pulses of electric current, has a therapeutic effect, and the avoidance of side effect in the form of local allergic reactions and the need to maintain the temperature regime of the drug in the treatment of gastrointestinal pathology calves non-infectious etiologies, by influence on biologically active points (BAP) drug and electro.

The technical result of the invention is the preparation does not require the maintenance of a certain temperature without causing significant local allergic reactions and concerns of the animal. The amount of preparation is reduced by 6-10 times compared to the recommended doses, thereby reducing the cost of treatment.

This technical result is achieved by the fact that exposure to perform external therapeutic massage electrode # 1 device "DiaDENS-PC" in the "Therapy" with alternating pulses of a frequency of 77 and 10 Hz on acupuncture points located along the median sagittal line between the spinous processes of the thoracic section of the spine, for 5 minutes, followed by the introduction of the drug Larsen" in a dose of 0.5 ml in the field biologists who Eski active points, located between the spinous processes of the last thoracic and first lumbar vertebrae.

The method of treatment is illustrated by example.

Example 1.

Calves in three more goals before the age of one month, a diagnosis of gastro-intestinal pathology of non-infectious etiology.

Clinical indications: diarrhoea, the animal's overall condition is satisfactory.

Treatment: acupuncture points located along the median sagittal line between the spinous processes of the thoracic section of the spine (for example, between 1-m and 2-m 3-m 4-m 5-m 6-m 6-m 7-m 8-m 9-m 10-m 11-m; the 11th and 12th thoracic vertebrae), was affected by external therapeutic massage electrode # 1 device "DiaDENS-PC" in the "Therapy" with alternating pulses of a frequency of 77 and 10 Hz for 5 minutes, moving the electrode smoothly, straight-line movements. After electroacupuncture therapy produced subcutaneous administration of the drug Larsen" in a dose of 0.5 ml in the area of biologically active points located between the spinous processes of the last thoracic (13) and the first lumbar vertebrae, which corresponds to the point acupuncture 17 described Gwithian.

The session was repeated with an interval of four days, the total number of sessions was 11.

Through three sessions of electroacupuncture and homeopathy at Elat stopped diarrhea, after 11 session blood biochemical parameters were consistent with physiological norm.

The proposed method has a stimulating effect on the acupuncture points without the risk of local allergic reactions, anxiety of the animal and causes a reaction of the organism. The use of the drug "Larsen at BAT reduces its quantity in 6-10 times to 0.5 ml and achieve a therapeutic effect.

The method does not require maintaining the temperature regime of the drug, when this has no side effects, does not cause local allergic reactions and concerns of the animal.

The method of treatment of gastrointestinal pathology calves non-infectious etiology, including the effects of drug on acupuncture points, characterized in that the impact perform external therapeutic massage electrode # 1 device "DiaDENS-PC" in the "Therapy" with alternating pulses of a frequency of 77 Hz and 10 Hz on acupuncture points located along the median sagittal line between the spinous processes of the thoracic section of the spine, for 5 min, followed by the introduction of the drug Larsen" in a dose of 0.5 ml in the area of biologically active points located between the spinous processes of the last thoracic and first lumbar vertebrae.



 

Same patents:

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely surgery, and may be used for treating trophic ulcers. That is ensured by preparing an autoplasma heparin preparation. Before coating with the precipitate, the ulcer surface is covered with proper cells of a dermal surface layer.

EFFECT: invention enables treating effectively trophic ulcers in the patients suffering diabetes mellitus.

1 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to pharmaceutical industry, namely to an agent possessing antilitogenic action. The use of the agent of lyophilised, homogenised, fresh-frozen swine kidneys, as an agent having antilitogenic action.

EFFECT: agent is effective for treating urolithiasis.

4 tbl, 3 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: present invention refers to food and pharmaceutical industry, namely the production of biologically active additives used for prevention of the conditions caused by vitamin and mineral deficiency, i.e. a powder for solution. The vitamin-mineral product contains a prebiotic (either sorbitol, or isomalt, or lactulose, or inulin), citric acid, a flavour, vitamins and minerals - retinol palmitate, alpha-tocopherol acetate, ascorbic acid, colecalciferol, nicotinamide, zinc, iodine, iron, selenium. The product represents a powder of weight 2.00.3 g.

EFFECT: vitamin-mineral product according to the invention is characterised by dosage uniformity, storage stability, bioavailability and neutral taste.

4 cl, 8 tbl, 6 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: there are offered: a pharmaceutical composition for preventing or treating atherosclerosis, metabolic syndrome, diabetes, obesity or their symptoms, or the combinations thereof, containing a pharmaceutically effective amount of D-tagatose or a salt, sugar alcohol, hydrate, solvate, ester or amide thereof, and a pharmaceutically effective amount of a second pharmaceutically active agent containing stilbene or a stilbenoid component or any salt, alcohol, hydrate, ester, amide, polymorph, isomer thereof, or a combination thereof, a related method of treating or preventing these diseases, the use of said composition for preparing a medicine or vaccine for the same application and a food stuff containing a pharmaceutically effective amount of D-tagatose or a salt, sugar alcohol, hydrate, solvate, ester or amide thereof, and a pharmaceutically effective amount of a second pharmaceutically active agent containing stilbene or a stilbenoid component or a salt, alcohol, hydrate, ester, amide, polymorph, isomer thereof, or a combination thereof.

EFFECT: declared combination reduces blood plasma triglyceride, including in additional carbon diet.

30 cl, 3 ex

Novel methods // 2484821

FIELD: medicine, pharmaceutics.

SUBSTANCE: there are presented: the use of aclidinium for preparing a medicine for treating or preventing a respiratory disease or condition in a patient by inhalation, wherein said patients showed no systemic antimuscarinic actions, where the patient suffers a condition or is susceptible thereto, which may be exacerbated by systemic antimuscarinic activity (versions), and a related method of treating or preventing.

EFFECT: invention provides local therapeutic action of aclidinium in lungs and has no significant systemic antimuscarinic action as it quickly hydrolysed in blood plasma, and its main metabolites are completely deprived of affinity to muscarinic receptors.

13 cl, 3 ex

FIELD: medicine.

SUBSTANCE: claimed invention relates to granulated from liquid pharmaceutical compositions, which contain rhein or diacerein, or their salts, and pharmaceutically acceptable carrier. Compositions contain from 20 to 45 mg of rhein or diacerein. Invention also relates to methods of producing claimed compositions. Compositions by invention are bioequivalent to preparative form of diacerein in dosage 50 mg, sold under the trade name Art 50. Compositions do not demonstrate variability in after meal condition and on an empty stomach.

EFFECT: considerable reduction of side effects, such as pulpy stool, in comparison with Art 50.

13 cl, 37 tbl, 17 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: claimed invention relates to field of pharmaceutics and medicine and deals with medication for treatment or prevention of diseases, mediated by mast cells, including neramexane or its pharmaceutically acceptable salt.

EFFECT: medication has high efficiency with respect to treatment or prevention of diseases, mediated by mast cells.

28 cl, 1 dwg, 17 tbl, 1 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention relates to pharmaceutical industry, namely to enzymatic wound healing medication. Enzymatic wound healing medication, which contains enzyme ultra-lysine in form of liquid substance, antiseptic myristamide and auxiliary substances - emuksol-268 and polyethyleneglycol, taken with specified ratio.

EFFECT: medication has increased wound healing activity.

4 dwg, 7 ex

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to gynecology, endocrinology and can be used for correction of vaginal dysbiosis in case of metabolic syndrome. For this purpose complex impact on the organism by correction of body weight by means of no-pharmaceutical and pharmaceutical preparations is performed. Hypocaloric diet with reduced caloric content of 500-600 kcall/day, with reduced content of fats in food up to 20-30% and hypolipidemic direction is administered. Increased physical activity and xenical preparation are also administered for 6 months. Correction of metabolic disorders is carried out by means of preparations possessing antioxidant and membrane-stabilising action daily for 3 months. Recovery of vaginal microflora is performed by means of preliminary sanitation of vaginal biotope with antibacterial preparations for 7 days and immunocorrection for 10 days with further administration of eubiotic preparations for 5-7 days. Correction of vaginal dysbiosis is carried out until amount of opportunistic bacteria decreases and/or content of normal microflora is recovered.

EFFECT: method ensures increased efficiency of correction of dysbiotic vaginal disturbances in case of metabolic syndrome.

1 ex, 1 tbl, 3 dwg

FIELD: chemistry.

SUBSTANCE: invention relates to a pyridine thio-derivative of general formula (I) or pharmaceutically acceptable salts thereof: , where R1 and R2, respectively, denote a hydrogen atom; R3 and R4, respectively, denote a hydrogen atom or a C1-8alkyl group; X denotes -O- or -S-; Y denotes a C1-12alkyl group, which can be substituted with a substitute selected from a group consisting of a hydroxyl group, C1-8alkoxy group or -(R5-O)n-R6 (where R5 denotes a C1-5alkylene group, R6 denotes a C1-8-alkyl group which can be substituted with a halogen atom, and n denotes an integer from 1 to 2) and Z denotes a hydrogen atom. The invention also relates to pharmaceutical compositions based on said compounds, having antibacterial activity towards Helicobacter pyroli.

EFFECT: obtaining novel compounds and a pharmaceutical composition based on said compounds, which can be used in medicine to prevent or treat diseases in which Helicobacter pylori participates, specifically gastritis, gastric ulcers, duodenal ulcers, gastric MALT lymphoma, hyperplastic gastric polyps or gastrointestinal malignant diseases.

10 cl, 3 tbl, 14 ex

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to gynaecology. The method involves conducting the dehydrating procedures. The procedures represent the exposure to pulse current. The exposure is characterised by pulse duration 1-6 ms, frequency 1-4 Hz, and current intensity 10-99 mA. Two electrodes are placed in the inguinal region, and another two electrodes are placed in a projection of a cistern of the thoracic duct flow. The exposure length is 20-25 minutes for 5-6 days.

EFFECT: method improves an ability of the hysteromyoma tissue to absorb focused ultrasound.

2 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to medicine, namely, urology, neurosurgery and vertebrology. Two temporary electrodes are intraoperatively inserted into the epidural space of the spinal cord under X-ray control. The first epidural electrode anode is inserted at the level of the segments L1-L2, and the second electrode cathode - at the level of the roots S2-S4. That is followed by postoperative electric neurostimulation by weak electric current for 10 minutes, 10 days every day.

EFFECT: method extends the range of products for treating neurogenic bladder in the patients with traumatic spinal disease.

3 dwg, 1 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to medicine, namely neurology, neurosurgery, physiotherapy. The method involves the drug-dosed administration of a therapeutic mixture of clonidine and morphine into the epidural space and electrostimulation of the spinal cord by pulsed electric current. For this purpose, electrodes are inserted into the epidural space above and below the lumbar enlargement. It is combined with percutaneous electrostimulation of the neuromuscular apparatus of the lower extremities. For this purpose, electrodes are applied in number of one for each region: a projection of the tibial nerve in the popliteal fossa, in a projection of the fibular nerve at the level of the fibular head, within the ankle posteriorly the medial malleolus, on an anterior surface of the lower one-third of the shin at a foot flexura between the tendons of the extensor digitorum longus and the extensor pollicis longus. The sessions of spinal electrostimulation and percutaneous electrostimulation of the neuromuscular apparatus of the lower extremities' are alternated, starting with spinal electrostimulation, in total no more than 4-5 times a day.

EFFECT: method provides reduction of spastic and spastic-pain syndrome due to the exposure to all the pathogenic mechanisms forming them.

3 cl, 1 ex

FIELD: medicine.

SUBSTANCE: invention is referred to medicine, namely to neurology. What is involved is electric stimulation of lower extremity muscles in 'myoneuroton' apparatus combined with stationary cycling. Electrodes are placed on right and left lower extremity muscles and attached to outputs of apparatus channels: hip flexors to the 1st and 5th channels, foot flexors to the 2nd and 6th channels, hip extensors to the 3rd and 7th channels, foot extensors to 4th and 8th channels. The treatment regimen implies a stimulation-relaxation practice. The 1st, 2nd, 5th and 6th channels are tuned to the stimulation regimen; the 3rd, 4th, 7th and 8th channels - to the relaxation regimen. The stimulation is generated by pulse semi-sinusoid current of frequency 35 Hz in the stimulation regimen, of frequency 120 Hz in the relaxation regimen, of pulse duration 120 ms, modulation frequency 9 Hz with current intensity adjusted to mild vibrating sensation. Action time of the channel group is 2 sec, and the patient cycles in the comfortable running. The 15-minute procedures are daily; the therapeutic course is 10 procedures.

EFFECT: method extends the range of products for treating infantile cerebral paralysis.

2 ex

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to vascular surgery. What is involved is radio-frequency ablation of vascular malformations to coagulated tissue resistance of 350-600 Ohm. Thermal exposure is generated by an ultrasound-aided needle electrode for 3-15 sec. The electrode is inserted from one prick in more than one directions or from more than one pricks.

EFFECT: method reduces injuries accompanying treating vascular malformations.

2 ex

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to physiotherapy, neurology. Method includes electric stimulation of spinal cord through epidural of epicutaneous electrodes. First, basic electric stimulation with placement of cathode and anode in projection of cervical intumescence of spinal cord at the level of C5-Th1 vertebrae is performed. After that, selective electric stimulation with placement of anode on belly of paretic muscle and cathode - at the level of segments of cervical intumescence segments which innervate it. In case of reduced muscle tone impact with frequency 0.5-2 Hz is carried out. In case of increased muscle tone impact with frequency 3 Hz is performed with periodic potentiation with frequencies 3-7-12 Hz.

EFFECT: method is used for restoration of arm movements in case of paralyses of different etiology and level of nervous system affection: caused by trauma of cervical spine, spine deformations or instability, inflammatory diseases of spine, defects of development, consequences of stroke and infantile cerebral palsy due to impact on motorneurons of cervical intumescence of spinal cord and arm muscles, which are innervated by them.

3 ex, 2 dwg

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to psychotherapy, reflexotherapy, physiotherapy. Method includes carrying out bioresonance testing (BRT) of functional state by means of hardware-software complex Vitatest. After that, with patient in lying on back position, transcranial electrostimulation (TES) and trance guidance at the background of aromatherapy and relaxation music for 20-25 minutes. After that, painful zones on hands and feet are detected and reflexotherapeutic impact is performed on detected zones until pain disappears. Further impact is performed depending on detected during BRT disorders. In case of dominating asthenic-depressive manifestations impact is performed in accordance with Su Jok correspondence system on points and zones of brain projection of anti-depressive direction, located on pads of distal feet phalanxes, reflexotherapy of corporal points VC14 jujue 1.5 cun lower than xiphoid precess of sternum, on the middle line of abdomen, anti-depressive herbal drugs with are administered for one month from beginning of cycles of procedures. In case of asthenic and vegetative-vascular manifestations rexlexotherapy is performed on points of heart projections on palms and little toes, on corporal points C4, C9 with administration of stimulating medications - bioadaptogens for 1-2 months. In case of anxiety and phobic disorders, R1 points are stimulated with intake of sedative phytopreparations for 1-3 months. In case of chronic fatigue impact is performed on corporal points TR1, point and deep massage of cervical-collar zone is performed and course of neuroprotectors - essential amino acids is administered for 1 to 3 months symptoms disappear completely. In case of post-trauma stress disorder, reflexotherapeutic impact is performed on the 1-st, 6-th and 11-th days in corporal points IG-8, J-17by sedative method, on the 2-nd, 7-th, 14-th day in points F-8, J-4, R-12 - by tonic method with intake of allopathic and homeopathic preparation with sedative action for 1-3 months.

EFFECT: method reduces treatment terms with increase of remission duration from 10 months to one year.

5 ex

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely neurology, physiotherapy. A method involves exposure of a patient's spinal cord above thoracic spines T11-T12. The patient is laid on one side with his/her feet supported by rocking frames. An active electrode is applied on skin. The exposure length is 10-20 seconds. The patient is exposed to a square electric bipolar stimulus sequence. The exposure amplitude is 40-70 mA, frequency is 5-40 Hz, and length is 0.5 m seconds. The carrier frequency is 10 kHz.

EFFECT: method provides higher clinical effectiveness ensured by rhythmic alternating activity in flexor and extensor muscles.

1 tbl, 6 dwg

FIELD: medicine.

SUBSTANCE: method of including impact on affected zones of spine with low-frequency pulse current. Current has exponential form. Frequency of pulse repetition is 50 Hz. Pulse duration changes to 50 ms. Impact is performed in three modes. In the first mode impact cycle corresponds to 1 second. In the second mode it changes from 2 to 20 seconds. In the third mode continuous cycle of impact is performed. Impact is performed on zone, adjacent to zone of affection, 3-7 cm distant from it, including healthy zone of spine.

EFFECT: method reduces treatment terms, strengthens muscular corset.

2 ex

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to otorhinolaryngology. On 3-4 day after surgery performed is course of neuromuscular electrophonopedic larynx stimulation on apparatus Vocastim-Master. Preliminarily ability of neuro-muscular larynx apparatus to accommodation is determined and its coefficient is found. After that, during first six minutes larynx muscles are subjected to impact of low-frequency pulse current, with electrodes being placed on front and back surface of neck. Then, 20-minute stimulation of vocal cords with simultaneous phonopedy is performed. Course of treatment consists of 10 daily procedures. Procedures are carried out 1-2 times per day, for 25-27 minutes.

EFFECT: method reduces terms of voice function recovery due to normalisation of clinical-functional state of larynx, accelerates reparative processes in post-operation region and prevents development of false-cord phonation and hypotonic disorder due to formation of physiological phonation.

2 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to pharmaceutical industry, particularly to a product for cardiovascular diseases. The medicinal herbal tea for cardiovascular diseases containing clover blossom and leaves, red-haw hawthorn blossom and fruit, melilot herb, motherwort herb, hop seedballs, knot grass herb, bedstraw herb, yellow cress herb, inula roots, clover leaves, red-haw hawthorn fruit, Patrinia scabiosifolia herb and roots, hazel leaves, meadow pine herb, yam roots, bur beggare herb, bicotor lespedeza leaves, dandelion herb and roots, Dahurian bugbane roots, black nightshade herb, linen seed, Dahurian moonseed roots and herb, belvedere herb, garlic roots, flaxweed herb, raspberry leaves, wormwood herb, dish mustard herb, Atractilodes ovata roots, Fragaria viridis leaves and fruit, Odontites serotina herb, lemon lily herb, laminaria leaves, Chinese magnolia vine fruit, Populus tremula bark, Polemonium racemosum herb and roots, an elevated part of fennel, common borage herb, May lily herb and blossom, flaxweed herb, marigold blossom, saw-wort herb, hill-growing saltwort herb, balm lemon leaves and blossom taken in certain proportions.

EFFECT: product has an integrated effect on the cardio vascular system and is effective for cardiovascular diseases.

4 ex

Up!